ESC Premium Access

Frequency, management and outcomes of patients with stable coronary artery disease eligible for COMPASS. An analysis of the CLARIFY registry.

Congress Presentation

About the speaker

Doctor Emmanuel Sorbets

Hospital Hotel-Dieu, Paris (France)
3 presentations
0 follower

3 more presentations in this session

State of the Art - New options in antithrombotic therapy for coronary artery disease

Speaker: Professor K. Newby (Durham, US)


Atherothrombotic risk and outcomes following guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome:a post-hoc analysis of the TROPICAL-ACS trial

Speaker: Assistant Professor K. Rizas (Munich, DE)


Secondary prevention in 2030: will antiplatelets or anticoagulants prevail?

Speaker: Professor D. Angiolillo (Jacksonville, US)


Access the full session

Antithrombotic therapy for coronary artery disease: opportunities and challenges

Speakers: Doctor E. Sorbets, Professor K. Newby, Assistant Professor K. Rizas, Professor D. Angiolillo

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb